Insider Transactions in Q2 2025 at Kymera Therapeutics, Inc. (KYMR)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2025
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
317,167
+8.02%
|
$13,955,348
$44.0 P/Share
|
Jun 30
2025
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
655,500
+9.15%
|
$28,842,000
$44.0 P/Share
|
Jun 11
2025
|
Elena Ridloff |
SELL
Open market or private sale
|
Direct |
4,500
-100.0%
|
$225,000
$50.0 P/Share
|
Jun 11
2025
|
Elena Ridloff |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
$90,000
$20.29 P/Share
|
Jun 03
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
6,349
-100.0%
|
$311,101
$49.0 P/Share
|
Jun 03
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
6,349
+50.0%
|
$63,490
$10.34 P/Share
|
Jun 03
2025
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-4.34%
|
$1,470,000
$49.0 P/Share
|
Jun 03
2025
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.16%
|
$60,000
$2.08 P/Share
|
Jun 03
2025
|
Elena Ridloff |
SELL
Open market or private sale
|
Direct |
12,000
-80.0%
|
$552,000
$46.25 P/Share
|
Jun 03
2025
|
Elena Ridloff |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$324,000
$27.67 P/Share
|
Jun 03
2025
|
Pamela Esposito |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$245,000
$49.04 P/Share
|
Jun 03
2025
|
Pamela Esposito |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$145,000
$29.55 P/Share
|
May 23
2025
|
Jeremy G Chadwick Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,575
-3.73%
|
$74,675
$29.3 P/Share
|
Apr 08
2025
|
Noah Goodman Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+49.96%
|
-
|